Image for post
Image for post

Swiftscale Biologics is Racing to Scale Up a Treatment for COVID-19 / Looking for Key Hires

The COVID-19 pandemic is a crisis that threatens to overwhelm the healthcare system and cause widespread mortality. The medical and pharmaceutical community must act quickly to develop treatments to prevent the unmitigated spread of this disease. One of the companies created last year in our 8VC build program, SwiftScale Biologics, is working hard to meet this challenge.

SwiftScale was co-founded last year by 8VC’s entrepreneur-in-residence, David Mace, along with professors Matthew DeLisa of Cornell and Michael Jewett of Northwestern who developed the foundational technology. …


Joe Lonsdale

Joe Lonsdale is a founding partner at 8VC, a San Francisco-based venture capital fund.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store